A major discovery that brings a new drug target to the increasingly exciting landscape of cancer immunotherapy was published yesterday by researchers from La Jolla Institute for Allergy and Immunology and their collaborators from other institutes.
4/3/2014 3:00 PM EDT
Researchers from the La Jolla Institute for Allergy and Immunology have revealed a critical player in the cellular interactions leading to eczema – a chronic inflammatory skin condition affecting more than 14 million U.S. children and adults.
1/9/2014 12:00 PM EST
A major new finding that will significantly advance efforts to create the world’s first antibody-based AIDS vaccine was published today by researchers from the La Jolla Institute for Allergy and Immunology.
9/10/2013 6:25 PM EDT
La Jolla Institute for Allergy and Immunology has earned the Number 1 ranking in The Scientist magazine’s 2013 “Best Places to Work in Academia” survey of the worldwide academic research community.
8/8/2013 8:00 AM EDT
La Jolla Institute for Allergy and Immunology and Kyowa Hakko Kirin California, Inc. (KKC), a wholly-owned subsidiary of Kyowa Hakko Kirin Co., Ltd. (KHK), a global specialty pharmaceutical company, today announced the signing of a new agreement...
7/30/2013 6:00 AM EDT
Herbert A. Wertheim, O.D., D.Sc., M.D. (hc), a noted inventor, philanthropist, and optometric and visual science industry pioneer, has been elected to La Jolla Institute for Allergy and Immunology’s Board of Directors.
7/17/2013 6:00 AM EDT
A major study from researchers at the La Jolla Institute for Allergy and Immunology provides new revelations about the intricate pathways involved in turning on T cells, the body’s most important disease-fighting cells, and was published today in...
6/21/2013 4:25 PM EDT
Seeking to improve the lives of sickle cell anemia sufferers around the world, researchers from the La Jolla Institute for Allergy and Immunology, the Dana-Farber/Children's Hospital Cancer Center in Boston and the BloodCenter of Wisconsin in...
6/11/2013 3:00 PM EDT